A phase I study to evaluate the safety, tolerability, pharmacodynamic and pharmacokinetic profiles of ocular GLH8NDE in healthy male adults-Reference-Cited by-同舟云学术

A phase I study to evaluate the safety, tolerability, pharmacodynamic and pharmacokinetic profiles of ocular GLH8NDE in healthy male adults

Published:2021-09-15 Issue: Volume: Page:
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Jung Jihyun¹²^ORCID,Huh Ki Young¹²^ORCID,Jin Xuanyou¹²^ORCID,Ha Ahnul³,Park Ki Ho⁴⁵,Park Jun Sang⁶,Kim Eunjung⁶,Lee Jaehwi⁷,Jang In‐Jin¹²,Lee Howard¹²⁸⁹¹⁰^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine Seoul Korea

2. Department of Clinical Pharmacology and Therapeutics Seoul National University Hospital Seoul Korea

3. Department of Ophthalmology Jeju National University Hospital Jeju Korea

4. Department of Ophthalmology Seoul National University College of Medicine Seoul Korea

5. Department of Ophthalmology Seoul National University Hospital Seoul Korea

6. GL PharmTech Corporation Gyeonggi‐do Korea

7. College of Pharmacy Chung‐Ang University Seoul Korea

8. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology Seoul National University Seoul Korea

9. Center for Convergence Approaches in Drug Development, Graduate School of Convergence Science and Technology Seoul National University Seoul Korea

10. Advanced Institute of Convergence Technology Gyeonggi‐do Korea

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13150

Reference37 articles.

1. Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis

2. Prevalence of dry eye disease and its association with dyslipidemia

3. Dry Eye Disease

4. Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease

5. Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Dry Eye Disease Treatment: Evidence From Randomized Controlled Trials;Eye & Contact Lens: Science & Clinical Practice;2023-09-20

2. Pretreatment with Eupatilin Attenuates Inflammation and Coagulation in Sepsis by Suppressing JAK2/STAT3 Signaling Pathway;Journal of Inflammation Research;2023-03

3. Eupatilin: Sources, Extraction, Derivatives, and Pharmacological Activity;Handbook of Dietary Flavonoids;2023